Skip to content

Genetic Risks for Bicuspid Aortic Valve Disease

Genetic Risks for Bicuspid Aortic Valve Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01823432
Enrollment
454
Registered
2013-04-04
Start date
2012-03-31
Completion date
2022-09-19
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bicuspid Aortic Valve, Unicuspid Aortic Valve

Brief summary

Bicuspid Aortic Valve (BAV) is the most common congenital heart malformation in adults, but very little is known about the genetic causes or risk factors for adverse outcomes. Currently, it is estimated that most cases of aortic stenosis in patients less than 65 years old are caused by BAVs. BAV patients are also at high risk to develop aneurysms of the ascending aorta, which may lead to aortic dissections. Dr. Prakash and his colleagues plan to use individual genetic information to identify persons with BAV who are at high risk for complications and to customize therapies.

Detailed description

To be included in the study, patients must have a bicuspid or unicuspid aortic valve, documented by clinical history or imaging studies. If the aortic valve was replaced surgically, they may still be eligible. Participants will be asked to donate a single tube of blood and fill out a questionnaire. Patients will also be followed up by telephone or email about once a year to determine if they experience any medical complications related to Bicuspid Aortic Valve (BAV), such as aortic aneurysms, aortic dissections or valve disease. Patients may not be included if they are less than 18 years old at the time of recruitment or have a recognized genetic syndrome or genetic mutation such as Marfan or Ehlers-Danlos syndrome.

Interventions

None listed

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At least 18 years of age * Diagnosis of bicuspid or unicuspid aortic valve

Exclusion criteria

* Less than 18 years of age * Recognized syndrome or identified genetic mutation

Design outcomes

Primary

MeasureTime frameDescription
Thoracic aortic aneurysms and dissections10 yearsDevelopment of new aneurysms and/or dissections of the thoracic aorta
Aortic valve replacement surgery10 years

Secondary

MeasureTime frameDescription
Aortic enlargement10 yearsDilation of thoracic aorta, new or progressive

Other

MeasureTime frameDescription
Aortic valve degeneration10 yearsIncrease in valve degeneration score by at least 1 unit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026